Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial Results and Host Conference Call on Tuesday, F...
22 February 2017 - 12:00AM
Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) announced today that
it will host a webcast and conference call to discuss the Company’s
financial results for the quarter and year ended December 31,
2016, and provide a general business overview on Tuesday,
February 28, 2017, at 4:30 p.m. ET (1:30 p.m. PT).
Conference Call DetailsThe live
conference call on Tuesday, February 28, 2017, at 4:30
p.m. Eastern Time, can be accessed by phone by calling (844)
452-6828 from the United States and Canada or 1
(765)-507-2588 internationally and using the passcode 71935945. The
webcast can be accessed live on the Investor Relations section of
the Company's website at http://investors.portola.com. It will
be archived for 30 days following the call.
About Portola Pharmaceuticals,
Inc. Portola Pharmaceuticals is a
biopharmaceutical company developing product candidates that could
significantly advance the fields of thrombosis and other
hematologic diseases. The Company is advancing three programs,
including betrixaban, an oral, once-daily Factor Xa inhibitor;
AndexXa™ (andexanet alfa), a recombinant protein designed to
reverse the anticoagulant effect in patients treated with an oral
or injectable Factor Xa inhibitor; and cerdulatinib, a Syk/JAK
inhibitor in development to treat hematologic cancers. Portola's
partnered program is focused on developing selective Syk inhibitors
for inflammatory conditions. For more information,
visit www.portola.com and follow the Company on Twitter
@Portola_Pharma.
Investor Contact:
Ana Kapor
Portola Pharmaceuticals
ir@portola.com
Media Contact:
Julie Normart
Pure Communications
jnormart@purecommunications.com
415.946.1087
Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart
From Apr 2024 to May 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles